comparemela.com

Kyung Hoon Hwang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Oscotec/ADEL Initiates First-in-Human Dosing in Ph1 of Anti-MTBR Tau Antibody ADEL-Y01 In Alzheimer s Disease

/PRNewswire/ Oscotec Inc. and ADEL Inc. announced the dosing of the first healthy participant in its first-in-human study of ADEL-Y01 for the treatment of.

Kyonggi doSouth koreaJanssen pharmaSeungyong yoonKyung hoon hwangTaeyoung yoonUniversity of ulsan college medicineYuhan corpAsan medical centerPrnewswire oscotec incOscotec incMild cognitive impairmentClinical investigationUlsan collegeHoon hwangOscotec inc

Oscotec/ADEL Announce FDA Clearance of IND Application of ADEL-Y01 for the Treatment of Alzheimer s Disease

/PRNewswire/ Oscotec Inc. and ADEL Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the investigational new drug (IND).

South koreaKyonggi doSeung yong yoonJanssen pharmaJune hahnTaeyoung yoonKyung hoon hwangPrnewswire oscotec incDrug administrationAsan medical centerOscotec incYuhan corpUniversity of ulsan college medicineClinical investigationMild cognitive impairmentUlsan college

vimarsana © 2020. All Rights Reserved.